1. Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial. Issue 5 (May 2017) Authors: Ahrén, Bo; Masmiquel, Luis; Kumar, Harish; Sargin, Mehmet; Karsbøl, Julie Derving; Jacobsen, Sanja Hald; Chow, Francis Journal: Lancet Issue: Volume 5:Issue 5(2017) Page Start: 341 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of once-weekly semaglutide versus sitagliptin as add-on to metformin and/or thiazolidinediones in subjects with T2D (SUSTAIN 2). (October 2016) Authors: Chow, Francis; Ahrén, Bo; Masmiquel Comas, Lluís; Kumar, Harish; Sargin, Mehmet; Derving Karsbøl, Julie; Hald Jacobsen, Sanja Journal: Diabetes research and clinical practice Issue: Volume 120(2016)Supplement 1 Page Start: S122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs. (April 2019) Authors: Yang, Wenying; Ersoy, Canan; Wang, Guixia; Ye, Shandong; Liu, Jun; Miao, Heng; Asirvatham, Arthur; Werther, Shanti; Kadu, Priti; Chow, Francis Journal: Diabetes research and clinical practice Issue: Volume 150(2019) Page Start: 158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: A 26-week, randomised, treat-to-target trial. Issue 1 (January 2015) Authors: Kaneko, Shizuka; Chow, Francis; Choi, Dong Seop; Taneda, Shinji; Hirao, Koichi; Park, Yongsoo; Andersen, Thomas Hasseriis; Gall, Mari-Anne; Christiansen, Jens Sandahl; on behalf of the BOOST®: Intensify All Trial Investigators Journal: Diabetes research and clinical practice Issue: Volume 107:Issue 1(2015) Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Natural history and outcome in chinese patients with gastroenteropancreatic neuroendocrine tumours: - a 17-year retrospective analysis. Issue 1 (December 2016) Authors: Chan, Doris; Luk, Andrea; So, W.; Kong, Alice; Chow, Francis; Ma, Ronald; Lo, Anthony Journal: BMC endocrine disorders Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗